article · Oxford Medical Case Reports
Most endometrial cancer recurrences are seen within 3 years of radical treatment and are associated with various prognostic factors (tumor size, stage, grading, histotype…). Late relapses are considered rare. In this report, we present a case of a patient who was treated for endometrial adenocarcinoma. She underwent total resection and received four cycles of first-line adjuvant chemoradiation therapy using a combination of platinum salts and taxane. A total of 58 months later, the patient presented with chronic cough, and hemoptysis. A computed tomography scan revealed the presence of lung nodules suggestive of metastases. Biopsies were performed, showed infiltration of the bronchial mucosa by a poorly differentiated carcinoma of an endometrial origin. Our patient received two cycles of palliative chemotherapy but was lost to follow-up and eventually died. Imaging after hemoptysis revealed disease progression. Endometrial carcinoma patients treated with radical surgery (R0) can relapse after years of free disease. Thus, recommended: closer follow-up, clinical examination, symptom-based imaging.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1093/omcr/omad083
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
